Schmertzler Michael

Avg. Two Year Performance

(18%) Avg. Purchase Return
(9%) Compound
69% Avg. Sale Return
30% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return23%22%40%21%(18%)
Purchase Success Rate1 of 31 of 31 of 31 of 30 of 3
Average Sale Return7%19%21%53%69%
Sale Success Rate2 of 22 of 22 of 22 of 22 of 2

Ptc Therapeutics, Inc.

Drugs » Biotechnology

Director:

Holdings: 123.27K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Hamilton Lane Inc

Other » Other

10% Owner:

Holdings: 725.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Cytokinetics Inc.

Drugs » Biotechnology

:

Holdings: 4.34M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--